pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
News | Timely industry updates for pharma and biotech leaders
3 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
11 blockbuster drugs to look out for in 2025 | pharmaphorum
5 days ago · Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.
Life Sciences Industry Report 2025 PART 1 | pharmaphorum
3 days ago · In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
Verona says COPD drug is off to a flying start | pharmaphorum
5 days ago · Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
FDA issues first guidance on AI in medicine development
6 days ago · The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and biologics by publishing its first provisional guidance on the technology's ...
About pharmaphorum
2 days ago · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
Pills and polls: What the 2024 election means for pharma
2 days ago · President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per-month out-of-pocket ...
Deep Dive | A bimonthly magazine for in-depth pharma stories
pharmaphorum presents a bimonthly Deep Dive magazine with extended, visually appealing features on R&D, patients, market access, digital health, and more.
- Some results have been removed